Clinicopathologic analysis of micropapillary urothelial carcinoma of the upper urinary tract: implications for HER2-targeted therapy

Lien-Ping Chou,Che-Wei Hsu,Sheau-Fang Yang,Chung-Ta Lee,Yin-Chien Ou,Kun-Che Lin,Che-Yuan Hu,Yeong-Chin Jou,Yuh-Shyan Tsai,Nan-Haw Chow

DOI: https://doi.org/10.1016/j.clgc.2023.04.002

IF: 3.121

2023-04-22

Clinical Genitourinary Cancer

Abstract:We retrospectively investigated the clinical significance of micropapillary urothelial carcinoma of the upper urinary tract. This rare entity usually presents as a small and locally advanced disease with nodal metastasis. Patients with HER2-positive micropapillary urothelial carcinoma had a significantly higher risk of metastasis compared with HER2-negative tumors. HER2-targeted regimen deserves consideration in the treatment of patients with micropapillary urothelial carcinoma. Introduction/Background To determine the clinical significance of micropapillary urothelial carcinoma (MPUC) of the upper urinary tract (UTUC) and a potential therapeutic strategy. Patients and Methods A retrospective cohort study was conducted to examine the incidence of micropapillary UTUC from 2010 to 2018 and its clinicopathological characteristics. Clinical outcomes and cancer-specific survival (CSS) were compared between MPUC and conventional UTUC matched by stage within a six-month variation of receiving surgery. Results A total of 24 MPUC cases were identified out of 901 cases (2.7%) of Urothelial carcinoma (UC) of the renal pelvis and ureter. MPUC was significantly smaller ( 0.50, respectively) compared with match controls. Six MPUC patients (25%) developed metastasis to the liver, lymph nodes, and lung during follow-up. Patients with HER2-positive MPUC (3 of 4) had a significantly higher risk of metastasis compared with HER2-negative MPUC (3 of 20; p = 0.035). Conclusions MPUC is an aggressive variant of UTUC and usually presents as a small locally advanced disease. HER2 immunohistochemistry may identify the subset of patients with micropapillary UTUC that are candidates for targeted therapy . Microabstract We retrospectively investigated the clinical significance of micropapillary urothelial carcinoma of the upper urinary tract. This rare entity usually presents as a small and locally advanced disease with nodal metastasis. Patients with HER2-positive micropapillary urothelial carcinoma had a significantly higher risk of metastasis compared with HER2-negative tumors. HER2-targeted regimen deserves consideration in the treatment of patients with micropapillary urothelial carcinoma

oncology,urology & nephrology